Join BOPA
Back to news articles

CRUK Consent Form Publication Update

By BOPA Committee on 9th January 2024

The CRUK SACT regimen-specific consent form project team is pleased to announce that a number of new consent forms have been published. They are now available on the CRUK website at: www.cruk.org/sact_consent.

 

Hepatocellular Carcinoma

New forms added for atezolizumab – bevacizumab and lenvatinib.

Renal Cell Carcinoma

New form added for pembrolizumab.

Please share this update within your clinical teams or forward to the relevant lead cancer clinician for your organisation.

 

Best Wishes,

Lucy

Lucy Cox

Cancer Research UK Specialist Pharmacist – Cancer Information Lead

Latest News

By Joseph Williams on 30th April 2024

Pharmacists’ Essential Guide to Haematology – UCLH Cancer Academy

UCLH Cancer Academy would like to invite you to an educational program designed to help pharmacists’ understanding of malignant haematology. SACT-accredited pharmacists who are new to haematology or wish to…

Read article
By BOPA Committee on 30th April 2024

BOPA Passport and UTIC

Over the next few days we will rolling out an update to the current Passport content based on user feedback and errors highlighted. This includes updates to MCQs and a…

Read article
By BOPA Committee on 30th April 2024

Understanding targeted therapies and immunotherapies for cancer (UTIC)- learning course now available

ISOPP (The International Society of Oncology Pharmacy Practitioners) and BOPA (The British Oncology Pharmacy Association) are pleased to announce this joint collaboration project – UTIC (Understanding targeted therapies and immunotherapies…

Read article
By BOPA Committee on 30th April 2024

Clinical Pharmacy Congress Awards 2024

BOPA and Netty Cracknell have been shortlisted for the CPC 2024 awards!  For more information please the following website: CPC AWARDS 2024 SHORTLIST – Clinical Pharmacy Congress  

Read article